Estrogen and Progesterone Receptor Determinations in Breast Cancer—Technology, Biology and Clinical Significance

References

• Alanko A., Heinonen E., Scheinin T. M., Tolppanen E. M., Vihko R. Oestrogen and progesterone receptors and disease-free interval in primary breast cancer. Br. J. Cancer 1984; 50: 667–672
   PubMedGoogle Scholar
• Allegra J. C., Lippman M. E., Green L. Estrogen receptor values in patients with benign breast disease. Cancer 1979; 44: 228–231
   Google Scholar
• Andersen K. W., Mouridsen H. T., Castberg T. Organization of the Danish adjuvant trials in breast cancer. Dan. Med. Bull. 1981; 28: 102–106
   PubMed Web of Science ®Google Scholar
• Andersen J., Orntoft T., Poulsen H. S. Semiquantitative oestrogen receptor assay in formalin-fixed paraffin sections of human breast cancer tissue using monoclonal antibodies. Br. J. Cancer 1986; 53: 691–694
   PubMed Web of Science ®Google Scholar
• Anonymous. Adjuvant tamoxifen in early breast cancer. Lancet 1987; II: 191–192
   Google Scholar
• Beatson G. T. On the treatment of inoperable cases of carcinoma of the mammae: Suggestions for a new method of treatment, with illustrative cases. Lancet 1896; 104–107; 162–165
   Google Scholar
• Bloom H. J. G., Richardson W. W. Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br. J. Cancer 1957; 11: 359–377
   PubMed Web of Science ®Google Scholar
• Braunsberg H. Factors influencing the estimation of oestrogen receptors in human malignant breast tumours. Eur. J. Cancer Clin. Oncol. 1975; 11: 499–507
   Google Scholar
• Breast Cancer Committee Trials Office Scottish Trials. Adjuvant tamoxifen in the management of operable breast cancer. The Scottish trial. Lancet 1987; II: 171–175
   Google Scholar
• Caldarola L., Volterrani P., Caldarola B., Lai M., Jayme A., Gaglia P. The influence of hormone receptors and hormonal adjuvant therapy on disease-free survival in breast cancer. A multifactorial analysis. Eur. J. Cancer Clin. Oncol. 1986; 22: 151–155
   Google Scholar
• Chamness G. C., Huff K., McGuire W. L. Protamineprecipitated estrogen receptor. A solid-phase ligand exchange assay. Steroids 1975; 25: 627–635
   Google Scholar
• Chamness G. C., McGuire W. L. Scatchard plots. Common errors in correction and interpretation. Steroids 1975; 26: 538–540
   PubMed Web of Science ®Google Scholar
• Clark G. M., McGuire W. L., Hubay C. A., Pearson O. H., Marshall J. S. Progesterone receptors as a prognostic factor in stage II breast cancer. N. Engl. J. Med. 1983; 309: 1343–1347
   PubMed Web of Science ®Google Scholar
• Clark G. M., Osborne C. K., McGuire W. L. Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. J. Clin. Oncol. 1984; 2: 1102–1109
   PubMed Web of Science ®Google Scholar
• Clark J. H., Peck E. J., Jr. Nuclear retention of receptor-oestrogen complex and nuclear acceptor sites. Nature 1976; 260: 635–637
   Google Scholar
• Clark J. H., Peck E. J., Jr., Hardin J. W., Eriksson H. The biology and pharmacology of estrogen receptor binding. Relationship to uterine growth. Receptors and hormone action II, B. W. O'Malley, L. Birnbaumer. Academic Press, London 1978; 1–31
   Google Scholar
• DeSombre E. R., Carobne P. P., Jensen E. V. Special report: Steroid receptors in breast cancer. N. Engl. J. Med. 1979; 301: 1011–1012
   PubMed Web of Science ®Google Scholar
• DeSombre E. R., Thorpe S. M., Rose C. Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancer. Cancer Res. 1986; 46: 4256–4264, Suppl.
   Web of Science ®Google Scholar
• Dickson R. B., Kasid A., Huff K. K. Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17β-estradiol or v-Ha-ras oncogene. Proc. Natl. Acad. Sci. USA 1987; 84: 837–841
   PubMed Web of Science ®Google Scholar
• Edwards D. P., Chamness G. C., McGuire W. L. Estrogen and progesterone receptor proteins in breast cancer. Biochem. Biophys. Acta 1979; 560: 457–486
   PubMedGoogle Scholar
• Edwards D. P., Martin P. M., Horwitz K. B., Chamness G. C., McGuire W. L. Subcellular compartmentalization of estrogen receptors in human breast cancer cells. Exp. Cell Res. 1980; 127: 197–213
   PubMed Web of Science ®Google Scholar
• EORTC Breast Cancer Co-operative Group. Standards for the assessment of estrogen receptors in human breast cancer. Eur. J. Cancer 1973; 9: 379–381
   Google Scholar
• Feherty P., Farrer-Brown G., Kellie A. E. Oestradiol receptors in carcinoma and benign disease of the breast. An in vitro assay. Br. J. Cancer 1971; 25: 697–710
   PubMed Web of Science ®Google Scholar
• Fernö M., Borg Å., Norgren A. A comparison of two steroid receptor assays in breast cancer. Dextran coated charcoal and isoelectric focusing. Anticancer Res. 1983; 3: 243–246
   PubMed Web of Science ®Google Scholar
• Folca P. J., Glascock R. F., Irvine W. T. Studies with tritiumaelabelled hexoestrol in advanced breast cancer. Lancet 1961; 796–798
   Google Scholar
• Garola R. E., McGuire W. L. A hydroxylalpatite micromethod for measuring estrogen receptor in human breast cancer. Cancer Res. 1978; 38: 2216–2220
   Google Scholar
• Glascock R. F., Hoekstra W. G. Selective accumulation of tritium-labelled hexoestrol by the reproductive organs of immature female goats and sheep. Biochem. J. 1959; 72: 673–682
   PubMed Web of Science ®Google Scholar
• Goldhirsch A., Gelber R. Adjuvant treatment for early breast cancer. The Ludwig breast cancer studies. Natl. Cancer Inst. Monographs 1986; 1: 55–70
   Google Scholar
• Greene G. L., Nolan C, Engler J. P., Jensen E. V. Monoclonal antibodies to the human estrogen receptor. Proc. Acad. Sci. USA 1980; 77: 5115–5119
   PubMed Web of Science ®Google Scholar
• Greene G. L., Press M. F. Application of monoclonal antibodies against estrogen and progesterone receptors in the immunocytochemical evaluation of breast carcinomas. Immunological approaches to the diagnosis and therapy of breast cancer, R. L. Cariani. Plenum Publishing Corp., New York 1987
   Google Scholar
• Horwitz K. B., McGuire W. L., Pearson O. H., Segaloff A. Predicting a response to endocrine therapy in human breast cancer. A hypothesis. Science 1975; 189: 726–727
   PubMed Web of Science ®Google Scholar
• Horwitz K. B., McGuire W. L. Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J. Biol. Chem. 1978; 253: 2223–2228
   PubMed Web of Science ®Google Scholar
• Hähnel R., Woodings T., Vivian A. B. Prognostic value of estrogen receptors in primary breast cancer. Cancer 1979; 44: 671–675
   PubMed Web of Science ®Google Scholar
• Jensen E. V., Block G. E., Smith S., Kyser K., DeSombre E. R. Estrogen receptors and breast cancer response to adrenalectomy. Natl. Cancer Inst. Monographs 1971; 34: 55–70
   PubMedGoogle Scholar
• Jensen E. V., Hurst D. J., DeSombre E. R., Jungblut P. W. Sulfhydryl groups and estradiol-receptor interaction. Science 1967; 158: 385–387
   PubMedGoogle Scholar
• Jensen E. V., Jacobson H. I., Flesher J. W. Estrogen receptors in target tissues. Steroid dynamics, G. Pincus, J. Nakao, J. F. Tait. Academic Press, London 1966; 133–157
   Google Scholar
• Jensen E. V., Polley T. Z., Smith S., Block G. E., Ferguson D. T., DeSombre E. R. Prediction of hormone dependence in human breast cancer. Estrogen receptors in human breast cancer, W. L. McGuire, P. P. Carbone, E. P. Vollner. Raven Press, New York 1975; 37–56
   Google Scholar
• Jordan V. C., Jacobsen H. I., Keenan E. J. Determination of estrogen receptor in breast cancer using monoclonal antibody technology. Results of a multicenter study in the Unites States. Cancer Res. 1986; 46: 4237–4240, Suppl.
   Web of Science ®Google Scholar
• Jordan V. C., Zava D. T., Eppenburger U. Reliability of steroid hormone receptor assays. An international study. Eur. J. Cancer Clin. Oncol. 1983; 19: 357–363
   PubMedGoogle Scholar
• King W. J., DeSombre E. R., Jensen E. V., Greene G. L. Comparison of cytochemical and steroid-binding assays for estrogen receptor in human breast cancer. Cancer Res. 1985; 37: 4669–4671
   Google Scholar
• King W. J., Greene G. L. Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells. Nature 1984; 308: 745–747
   Google Scholar
• Kinne D. W., Ashikari R., Butler A., Menendez-Botet C, Rosen P. P., Schwartz M. Estrogen receptor protein in breast cancer as a predictor of recurrence. Cancer 1981; 47: 2364–2367
   PubMedGoogle Scholar
• Koenders T., Benraad T. J. Quality control of estrogen receptor assays in the Netherlands. Breast Cancer Res. Treat. 1983; 3: 155–166
   Google Scholar
• Koenders T., Thorpe S. M. (On behalf of the EORTC Receptor Group.) Standardization of steroid receptor assays in human breast cancer I. Reproducibility of estradiol and progesterone receptor assays. Eur. J. Cancer Clin. Oncol. 1983; 19: 1221–1229
   PubMedGoogle Scholar
• Koenders T., Thorpe S. M. (On behalf of the EORTC Receptor Group.) Standardization of steroid receptor assays in human breast cancer II. Samples with low receptor content. Eur. J. Cancer Clin. Oncol. 1983; 19: 1467–1472
   PubMedGoogle Scholar
• Koenders T., Thorpe S. M. (On behalf of the EORTC Receptor Group.) Standardization of steroid receptor assays in human breast cancer IV. Long-term within-and between-laboratory variance analysis of estrogen and progesterone receptor assays. Eur. J. Cancer Clin. Oncol. 1986; 22: 945–952
   PubMedGoogle Scholar
• Korenman S. G., Dukes B. A. Specific estrogen binding by the cytoplasm of human breast carcinoma. J. Clin. Endocrin. 1970; 30: 639–645
   PubMed Web of Science ®Google Scholar
• Knight W. A., Livingstone R. B., Gregory E. J., McGuire W. L. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res. 1977; 37: 4669–4671
   PubMed Web of Science ®Google Scholar
• Laing L., Smith M. G., Calman K. C., Smith D. C., Leake R. E. Nuclear oestrogen receptors and treatment of breast cancer. Lancet 1977; II: 168–169
   Google Scholar
• Leake R. E., Laing L., McArdle C., Smith D. C. Soluble and nuclear oestrogen receptor status in human breast cancer in relation to prognosis. Br. J. Cancer 1981; 43: 67–71
   Google Scholar
• Leclercq G., Bojar H., Goussard J. Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer. A European multicenter study. Cancer Res. 1986; 46: 4233–4236, Suppl.
   PubMed Web of Science ®Google Scholar
• Lykkesfeldt A. E., Briand P. Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell lines. Br. J. Cancer 1986; 53: 29–35
   PubMed Web of Science ®Google Scholar
• Magdelenat H., Merle S., Zajdela A. Enzyme immunoassay of estrogen receptors in fine needle aspirates of breast tumors. Cancer Res. 1986; 46: 4265–4267, Suppl.
   Web of Science ®Google Scholar
• Martin P. M., Rolland P. H., Jacquemier J., Rolland A. M., Toga M. Multiple steroid receptors in human breast cancer II. Estrogen and progestin receptors in 672 primary tumors. Cancer Chemother. Pharmacol. 1979; 2: 107–113
   PubMed Web of Science ®Google Scholar
• Martin P. M., Sheridan P. J. Intracellular distribution of estrogen receptors. A function of preparation. Experientia 1980; 36: 620–622
   Google Scholar
• Martin P. M., Sheridan P. J. Towards a new model for the mechanism of action of steroids. J. Steroid Biochem. 1982; 16: 215–229
   PubMedGoogle Scholar
• McCarty K. S., Jr., Miller L. S., Cox E. B., Conrath J., McCarty K S, Sr. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal anti-receptor antibodies. Arch. Pathol. Lab. Med. 1985; 109: 716–721
   PubMed Web of Science ®Google Scholar
• McGuire W. L. Steriod receptors in human breast cancer. Cancer Res. 1978; 38: 4289–4291
   PubMed Web of Science ®Google Scholar
• McGuire W. L. Steroid hormone receptors and disease. Breast Cancer. Proc. Soc. Exp. Biol. Med. 1979; 162: 22–25
   Google Scholar
• McGuire W. L. Prognostic factors in primary breast cancer. Cancer Surv. 1986; 5: 527–536
   PubMedGoogle Scholar
• McGuire W. L. Carbone P. P., Sears M. E. and Escher G. C.: Estrogen receptors in human breast cancer. An overview. Estrogen receptors in human breast cancer, W. L. McGuire, P. P. Carbone, E. P. Volmer. Raven Press, New York 1975; 1–8
   Google Scholar
• Namkung P. C., Moe R. E., Petra P. H. Stability of estrogen receptors in frozen human breast tumor tissue. Cancer Res. 1979; 39: 1124–1125
   Google Scholar
• Nolvadex Adjuvant Trial Organization. Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Lancet 1985; 836–840
   Google Scholar
• Notides A. C. Conformational form of the estrogen receptor. Receptors and hormone action II, B. W. O'Malley, L. Birnbaumer. Academic Press, London 1978; 33–61
   Google Scholar
• O'Connell M., McDonnell L., Duffy M. J. Studies on nuclear estradiol receptors in human mammary carcinomas. Clin. Chim. Acta 1982; 119: 285–289
   Google Scholar
• Osborne C. K., Yochmowitz M. G., Knight W. A., McGuire W. L. The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 1980; 46: 2884–2888
   PubMed Web of Science ®Google Scholar
• Ozzello L., DeRosa C, Habif D. V., Lipton R. Immunostaining of estrogen receptors in paraffin sections of breast cancer using anti-estrophilin monoclonal antibodies. Dev. Oncol. 1985; 35: 3–12
   Google Scholar
• Padmanabhan N., Howell A., Rubens R. D. Mechanism of action of adjuvant chemotherapy in early breast cancer. Lancet 1986; II: 411–414
   Google Scholar
• Pertschuk L. P., Eisenberg K. B., Carter A. C., Feldman J. G. Immunohistologic localization of estrogen receptors in breast cancer with monoclonal antibodies. Cancer 1985; 55: 1513–1518
   PubMed Web of Science ®Google Scholar
• Pertschuk L. P., Feldman J. G., Eisenberg K. B. Immunocytochemical detection of progesterone receptors in breast cancer with monoclonal antibody. Relation to biochemical assay, recurrence-free survival and clinical endocrine response, Submitted for publication
   Google Scholar
• Pinchon M. F., Pallud C, Brunet M., Milgrom E. Relationship of presence of progesterone receptors to prognosis in early breast cancer. Cancer Res. 1980; 40: 3357–3360
   Google Scholar
• Puca G. A., Bresciani R. Receptor molecule for estrogens from rat uterus. Nature 1986; 218: 967–969
   Google Scholar
• Rank F., Jespersen N. C. B., Pedersen B. V., Keiding N., Dombernowsky P. Histological malignancy grading of invasive ductal breast carcinoma. A regression analysis of prognostic factors in low-risk carcinomas from a multicenter trial. Cancer 1987; 60: 1299–1305
   PubMedGoogle Scholar
• Reiner G. C., Katzenellenbogen B. S. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cells. Cancer Res. 1986; 46: 1124–1131
   Google Scholar
• Rose C., Mouridsen H. T., Thorpe S. M., Andersen J., Blichert-Toft M., Andersen K. W. Anti-estrogen treatment of postmenopausal breast cancer patients with high risk of recurrence. 72 months of life-table analysis and steroid hormone receptor status. World J. Surg. 1985; 9: 765–774
   PubMed Web of Science ®Google Scholar
• Rose C., Thorpe S. M., Andersen K. W. Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values. Lancet 1985; 16–19
   PubMedGoogle Scholar
• Ryan E. D., Clark A. F., Mobbs B. G., Ooi T. C., Sutherland D. J. A., Tustanoff E. R. Inter-laboratory quality control of estrogen and progesterone receptor assays in breast cancer tissue using lyophilised cytosols. Clin. Biochem 1985; 18: 20–26
   PubMedGoogle Scholar
• Sainsbury J. R. C., Farndon J. R., Needham G. K., Malcolm A. J., Harris A. L. Epidermal-growth factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet 1987; I: 1398–1402
   Google Scholar
• Sarrif A. M., Durant J. R. Evidence that estrogenreceptor-negative, progesterone-receptor-positive breast and ovarian carcinomas contain estrogen receptor. Cancer 1981; 48: 1215–1220
   Google Scholar
• Scatchard G. The attractions of proteins for small molecules and ions. Ann. NY Acad. Sci 1949; 51: 660–672
   Web of Science ®Google Scholar
• Schinzinger A. Über carcinoma mammae. Verh. Dtsch. Ges. Chir. 1889; 18: 28–29
   Google Scholar
• Schrader W. T. New model for steroid hormone receptors. Nature 1984; 308: 17–18
   PubMed Web of Science ®Google Scholar
• Shimada A., Kimura S., Abe K. Immunocytochemical staining of estrogen receptor in paraffin sections of human breast cancer by use of monoclonal antibody. Comparison with that in frozen sections. Proc. Natl. Acad. Sci. USA 1985; 82: 4803–4807
   PubMed Web of Science ®Google Scholar
• Slamon D. J., Clark G. M., Wong S. T., Levin W. J., Ullrich A., McGuire W. L. Human breast cancer. Correlations of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177–182
   PubMed Web of Science ®Google Scholar
• Stewart H. J., Prescott R. Adjuvant tamoxifen therapy and receptor levels. Lancet 1985; 573
   Google Scholar
• Theillet C., Lidereau R., Escot C. Loss of a c-H-ras-l allele and aggressive human primary breast carcinoma. Cancer Res. 1986; 46: 4776–4781
   PubMedGoogle Scholar
• Thorpe S. M. Immunological quantitation of nuclear receptors in human breast cancer. Relation to cytosolic estrogen and progesterone receptors. Cancer Res. 1987; 47: 1830–1835
   PubMed Web of Science ®Google Scholar
• Thorpe S. M. Steroid receptors in breast cancer. Sources of interlaboratory variation in dextran-charcoal assays. Breast Cancer Res. Treat. 1987; 9: 175–189
   PubMed Web of Science ®Google Scholar
• Thorpe S. M. Monoclonal antibody technique for detection of estrogen receptors in human breast cancer. Greater sensitivity and more accurate classification of receptor status than dextran-coated charcoal method. Cancer Res. 1988; 6572–6575
   Google Scholar
• Thorpe S. M., Koenders A. (On behalf of the EORTC Receptor Group.) Standardization of steroid receptor assays in human breast cancer HI. Selection of reference material for intra-and inter-laboratory quality control. Eur. J. Cancer Clin. Oncol. 1986; 22: 939–944
   PubMedGoogle Scholar
• Thorpe S. M., Lykkesfeldt A. E., Vinterby Å., Lonsdorfer M. Quantitative immunological detection of estrogen receptors in nuclear pellets from human breast cancer biopsies. Cancer Res. 1986; 46: 4249–4250, Suppl.
   Google Scholar
• Thorpe S. M., Olsen K., Pedersen K. O., Poulsen H. S., Rose C. Quality control of estrogen and progesterone receptor analyses in Denmark. Recent Results Cancer Res. 1984; 91: 91–93
   PubMedGoogle Scholar
• Thorpe S. M., Poulsen H. S., Pedersen K. O., Rose C. (On behalf of the DBCG.) Impact of standardization of estrogen and progesterone receptor assays of breast cancer biopsies in Denmark. Eur. J. Cancer Clin. Oncol., In press
   Google Scholar
• Thorpe S. M., Rochefort H., Garcia M. High concentration of 52K cathepsin-D predict poor prognosis in primary. postmenopausal breast cancer 1988, Submitted for publication
   Google Scholar
• Thorpe S. M., Rose C. Oestrogen and progesterone receptor determinations in breast cancer. Technology and biology. Cancer Surv. 1986; 5: 505–525
   PubMedGoogle Scholar
• Thorpe S. M., Rose C. Biological and clinical relevance of Kd values for estradiol binding in primary breast cancer tumors. Eur. J. Cancer Clin. Oncol., In press
   Google Scholar
• Thorpe S. M., Rose C. Estrogen and progesterone receptor determinations in breast cancer. Biology and technology. Proceedings from First International Symposium on Breast Cancer, New Delhi, In press
   Google Scholar
• Thorpe S. M., Rose C., Pedersen B. V., Rasmussen B. B. Estrogen and progesterone receptor profile patterns in primary breast cancer. Breast Cancer Res. Treat. 1983; 3: 103–110
   Google Scholar
• Thorpe S. M., Rose C., Rasmussen B. B. Steroid hormone receptors as prognostic indicators in primary breast cancer. Breast cancer Res. Treat. 1986; 7: 91–98, Suppl.
   PubMed Web of Science ®Google Scholar
• Thorpe S. M., Rose C., Rasmussen B. B., Mouridsen H. T., Bayer T., Keiding N. (On behalf of the DBCG.) Prognostic value of steroid hormone receptors. Multivariate analysis of low risk, untreated primary breast cancer. Cancer Res. 1987; 47: 6126–6133
   PubMed Web of Science ®Google Scholar
• Toft D., Gorski J. A receptor molecule for estrogens. Isolation from the rat uterus and preliminary characterization. Proc. Natl. Acad. Sci. USA 1966; 55: 1574–1581
   PubMed Web of Science ®Google Scholar
• Underwood J. C. E. Oestrogen receptors in human breast cancer. Review of histopathological correlations and critique of histochemical methods. Diagn. Histopathol. 1983; 6: 1–22
   PubMedGoogle Scholar
• Vandewalle B., Peyrat J. P., Bonneterre J., Hecquet B., Dewailly D., Lefebvre J. Nuclear estradiol-binding sites in human breast cancer. Cancer Res. 1983; 43: 4497–4503
   PubMedGoogle Scholar
• Van Landeghem A. A. J., Poortman J., Nabuurs M., Thijssen J. H. H. Endogenous concentrations and subcelhilar distribution of estrogens in normal and malignant human breast tissue. Cancer Res. 1985; 46: 2900–2906
   Google Scholar
• Welshons W. V., Lieberman M. E., Gorski J. Nuclear localization of unoccupied oestrogen receptors. Nature 1984; 307: 747–749
   PubMed Web of Science ®Google Scholar
• Wilson A. J., Baum M., Brinkley D. M. Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. World J. Surg. 1985; 9: 756–764
   Google Scholar
• Wrange O., Nordenskjöld B., Silferswärd C, Granberq P. O., Gustavsson J. Å. Isoelectric focusing of estradiol receptor protein from human mammary carcinoma. A comparison to sucrose gradient analysis. Eur. J. Cancer 1976; 12: 695–700
   PubMed Web of Science ®Google Scholar
• Zava D. T., Wyler-von Ballmoos A., Goldhirsch A. A quality control study to assess the inter-laboratory variability of routine estrogen and progesterone receptor assays. Eur. Cancer Clin. Oncol. 1982; 18: 713–721
   Google Scholar